Edwards Lifesciences (EW) Tops Q4 EPS by 3c; Raises Outlook

Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $888.5 million versus the consensus estimate of $867.09 million.

GUIDANCE:

Edwards Lifesciences sees Q1 2018 EPS of $1.04-$1.14. Edwards Lifesciences sees Q1 2018 revenue of $3.5-3.9 billion.

Edwards Lifesciences sees FY2018 EPS of $4.43-$4.63. Edwards Lifesciences sees FY2018 revenue of $900-950 million.

For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• MP Materials seen largely insulated after China export-control move